Pharming Group N.V.

PHAR | NASDAQ

Price Alert Chart Builder DCF Calculator

$12.23

+$0.10 (+0.82%)

At close: Oct 30, 2026, 4:00 PM ET

$12.23

$0.00 (0.00%)

After-hours: Oct 30, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Net Income	12.85M	-8.49M	-12.01M	14.99M	23.08M	44.09M
Depreciation & Amortization	11.22M	16.07M	15.93M	13.19M	19.61M	8.31M
Stock-Based Compensation	13.77M	11.25M	9.25M	6.39M	9.06M	6.54M
Other Working Capital	15.03M	-2.79M	16.01M	12.27M	-4.73M	8.06M
Other Non-Cash Items	6.49M	-10.55M	-13.51M	-11.72M	-8.94M	28.6M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	10.39M	-10.07M	-16.96M	-387K	-4.96M	-3.92M
Operating Cash Flow	54.71M	-1.8M	-17.3M	22.46M	37.84M	83.63M
Capital Expenditures	-755K	-796K	-1.46M	-1.98M	-16.72M	-15.3M
Cash Acquisitions	-58.22M	n/a	n/a	7.3M	n/a	-329K
Purchase of Investments	-2K	-284.31M	-382.01M	n/a	-4.59M	n/a
Sales Maturities Of Investments	85.23M	316.73M	232.81M	n/a	n/a	n/a
Other Investing Acitivies	-1K	n/a	21.28M	n/a	n/a	n/a
Investing Cash Flow	26.25M	31.62M	-129.39M	5.32M	-21.31M	-15.63M
Debt Repayment	-4.25M	-34.39M	-4.04M	-3.31M	-3.22M	83.41M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-14.07M	-5.6M	-5.13M	-3.95M	-29.45M	-25.51M
Financial Cash Flow	1.5M	-34.41M	-1.04M	-4.98M	-27.95M	60.69M
Net Cash Flow	90.36M	-6.8M	-145.6M	15.42M	-13.24M	130.81M
Free Cash Flow	53.95M	-2.59M	-18.77M	20.48M	21.13M	68.33M
Adj. Free Cash Flow	40.19M	-13.84M	-28.02M	14.09M	12.07M	61.79M
Maintenance CapEx	n/a	n/a	n/a	-1.13M	-16.72M	-12.99M
Growth CapEx	-755K	-796K	-1.46M	-850.15K	n/a	-2.31M
Owner Earnings	54.71M	-1.8M	-17.3M	21.33M	21.13M	70.64M